Nilotinib treatment-associated peripheral artery disease and sudden death: Yet another reason to stick to imatinib as front-line therapy for chronic myelogenous leukemia

Ayalew Tefferi, Louis Letendre

Research output: Contribution to journalLetterpeer-review

64 Scopus citations
Original languageEnglish (US)
Pages (from-to)610-611
Number of pages2
JournalAmerican journal of hematology
Issue number7
StatePublished - Jul 2011

ASJC Scopus subject areas

  • Hematology

Cite this